Nektar Therapeutics (NASDAQ:NKTR) belongs to Healthcare sector. Its net profit margin is 9.00% and weekly performance is -14.09%. On last trading day company shares ended up $11.89. Nektar Therapeutics (NASDAQ:NKTR) distance from 50-day simple moving average (SMA50) is 3.02%. The Board of Directors of Nektar Therapeutics, (NASDAQ:NKTR) a Delaware corporation previously approved, subject to stockholder approval, an amendment to the Company’s 2012 Performance Incentive Plan (the “2012 Plan”) that would increase the number of shares of the Company’s common stock reserved for issuance under the 2012 Plan by an additional 7,000,000 shares. According to the final results from the Company’s 2015 Annual Meeting of Stockholders held on June 16, 2015 (the “Annual Meeting”), the Company’s stockholders approved the amendment to the 2012 Plan.
Geospace Technologies Corporation (NASDAQ:GEOS) shares decreased -5.51% in last trading session and ended the day at $21.28. GEOS Gross Margin is 19.60% and its return on assets is -2.50%. Geospace Technologies Corporation (NASDAQ:GEOS) quarterly performance is 32.34%.
On 02 July, The Chubb Corporation (NYSE:CB) shares advanced 1.23% and was closed at $121.47. CB EPS growth in last 5 year was 6.90%. The Chubb Corporation (NYSE:CB) year to date (YTD) performance is 18.77%. Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of The Chubb Corporation (NYSE:CB) for potential breaches of fiduciary duties in connection with the sale of the Company to ACE Ltd. for approximately $28.3 billion. The Company’s stockholders will only receive $62.93 in cash and 0.6019 share of ACE stock for each share they own for each share of Company common stock they own.
Onconova Therapeutics, Inc. (NASDAQ:ONTX) ended the last trading day at $2.70. Company weekly volatility is calculated as 8.72% and price to cash ratio as 1.74. Onconova Therapeutics, Inc. (NASDAQ:ONTX) showed a weekly performance of 6.30%. Onconova Therapeutics, Inc. (NASDAQ:ONTX) announced that Ramesh Kumar, Ph.D., President and Chief Executive Officer, will present a company update, including details of a new global Phase 3 trial in higher-risk myelodysplastic syndromes at the Cantor Fitzgerald Healthcare Conference in New York, NY. The presentation will take place on Wednesday, July 8th at 10:15 a.m. ET. Dr. Kumar will also participate in a panel discussion of biomarkers in clinical development.
Ecology & Environment, Inc. (NASDAQ:EEI) shares advanced 0.10% in last trading session and ended the day at $10.49. EEI Gross Margin is 44.00% and its return on assets is 2.60%. Ecology & Environment, Inc. (NASDAQ:EEI) quarterly performance is 18.80%. On 16 June, Ecology and Environment, Inc., (NASDAQ:EEI) reported a 9% increase in revenue from U.S. operations and continued reductions in operating expenses, leading to consolidated net income of $1.8 million ($0.42 per share) for the third quarter of fiscal year 2015, an improvement from a net loss of $0.3 million ($0.08 per share) reported in the third quarter of the prior year.